Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired.
The deal has already been approved by the boards of directors from both companies.
Founded in 2009, Shockwave focuses on intravascular lithotripsy technology that uses sonic pressure waves to crack calcium lesions in arteries and restore blood flow. It’s similar to a technique used to break up kidney stones. The soundwave emitters are placed inside angioplasty catheters to reach the calcified areas of the artery.
Shockwave’s technology is used to treat coronary artery and peripheral artery disease.
The company’s revenue jumped 49% last year to $730 million.
Sarah Jessica Parker divides opinion with enormous hat on set of And Just Like That
Canadian police arrest of fourth Indian suspect in killing of Sikh activist
Rise in UK knife attacks leads to a crackdown and stokes public anxiety
US aims to stay ahead of China in using AI to fly fighter jets
Georgia Republicans choose Amy Kremer, organizer of pro
Mother's Day: Today, more US parents than ever have paid leave — but most still don't
Afghanistan flash flooding: Hundreds dead and missing
Jessica Biel shows off her new blonde hair and casual
Queen Camilla reveals she's seen the first season of Bridgerton
Pictured: Grandmother, 66, stabbed to death near bus stop
'Real life' Martha from Baby Reindeer's million
Kaia Gerber exudes timeless glamour in a strapless minidress as she joins her co